Literature DB >> 22605805

Flash pulmonary oedema: a rare but serious side effect of quinine sulphate.

Dan Raine1, Alison Lee, Rachael Wiedmann.   

Abstract

A 54-year-old woman with a background of psoriatic arthritis but no cardiac history was admitted with acute pulmonary oedema (November 2007) which required invasive ventilation and inotropic support. Investigations including ECG, transthoracic and transoesophageal echocardiography, coronary angiography, renal ultrasound and renal magnetic resonance angiography, cardiac MRI and urinary catecholamines were normal. Due to the lack of precipitant, the authors assumed this was due to nabumetone (a non-steroidal anti-inflammatory drug (NSAID)) which was stopped. A second similar episode (August 2008) was temporally associated with a depo steroid injection, although no NSAID was given. Steroids have subsequently been restricted. However, she was admitted again with pulmonary oedema (April 2010) despite not taking NSAIDs or steroids. At that stage, she advised us that she had been taking quinine sulphate on an as required basis and had taken oral doses before each episode of pulmonary oedema which the authors now believe to have been the precipitant.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22605805      PMCID: PMC3316803          DOI: 10.1136/bcr.03.2011.4040

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

1.  Pulmonary edema in cerebral malaria patients in Thailand.

Authors:  B Aursudkij; P Wilairatana; S Vannaphan; D S Walsh; V R Gordeux; S Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  1998-09       Impact factor: 0.267

2.  Complications and mortality patterns due to Plasmodium falciparum malaria in hospitalized adults and children, Rourkela, Orissa, India.

Authors:  Sanjib Mohanty; Saroj K Mishra; Sudhansu S Pati; Jayakrushna Pattnaik; Bhabani S Das
Journal:  Trans R Soc Trop Med Hyg       Date:  2003 Jan-Feb       Impact factor: 2.184

3.  Acute pulmonary edema caused by quinine.

Authors:  Richard J Everts; Michael D Hayhurst; Basim P Nona
Journal:  Pharmacotherapy       Date:  2004-09       Impact factor: 4.705

4.  Transient pulmonary infiltrates possibly induced by quinine sulfate.

Authors:  Mori J Krantz; Richard C Dart; Philip S Mehler
Journal:  Pharmacotherapy       Date:  2002-06       Impact factor: 4.705

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.